PROKIDNEY CORP.

PROK · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
97
SEC Filings

Business Summary

Part I Item 1A, Risk Factors below and include, but are not limited to, risks related to: Our Financial Position and Need for Additional Capital our ability to achieve or maintain profitability; our ability to generate revenue in the absence of any products approved for sale; our need for additional capital to continue the development and commercialization of our drug candidates; the impact of raising additional capital to our stockholders and the rights of our drug candidates; Development of Re...

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPROKdiscussed_in_filing Cybersecurity
topic_mentionPROKdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-182025-12-310001193125-26-113881EDGAR106K words
2025-03-172024-12-310000950170-25-040483EDGAR—
2024-03-222023-12-310000950170-24-034946EDGAR—
2023-03-282022-12-310000950170-23-010324EDGAR—
2022-03-242021-12-310001193125-22-082906EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-274303EDGAR27K words
2025-08-122025-06-300000950170-25-107352EDGAR—
2025-05-122025-03-310000950170-25-069251EDGAR—
2024-11-122024-09-300000950170-24-125312EDGAR—
2024-08-092024-06-300000950170-24-094732EDGAR—
2024-05-102024-03-310000950170-24-057785EDGAR—
2023-11-142023-09-300000950170-23-063688EDGAR—
2023-08-102023-06-300000950170-23-041374EDGAR—
2023-05-112023-03-310000950170-23-021232EDGAR—
2022-11-142022-09-300000950170-22-024794EDGAR—
2022-08-122022-06-300001193125-22-218857EDGAR—
2022-05-162022-03-310001193125-22-151998EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-180001193125-26-113893EDGAR4K words
2026-02-020001193125-26-033594EDGAR—
2026-01-120001193125-26-009807EDGAR—
2025-11-100001193125-25-274314EDGAR—
2025-10-170001193125-25-242565EDGAR—
2025-08-120000950170-25-107357EDGAR—
2025-07-150001193125-25-159041EDGAR—
2025-07-140001193125-25-158806EDGAR—
2025-07-080000950170-25-094445EDGAR—
2025-07-010001140361-25-024348EDGAR—

97 total filings indexed. 70 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001850270
TickerPROK
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedE9

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f17f71201e51829f0836a44509564a2b5315c7a3a2eb711490271dc28e6a0fa3
parent: b0d2de4757d8a1f1bb0e2d35d71f206cccb7a23dec496f4a4585e593dea0ada2
content hash: 1c6a2fc5c3def6c375afc8124d6f31c54191994b7c78eb18dc8961d5c28aeeb3
signed: 2026-04-13T04:47:00.342Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf